HEPA
Price:
$0.052
Market Cap:
$605.47K
Hepion Pharmaceuticals, Inc., a U.S.-based biopharmaceutical entity, is dedicated to developing therapeutic interventions for chronic hepatic ailments. Central to their efforts is Rencofilstat, a cyclophilin inhibitor that has successfully concluded Phase 2a clinical trials. This compound operates by disrupting multiple pathological pathways implicated in the worsening of liver disease. It is currently progressing through clinical development for non-alcoholic steatohepatitis (NASH) and is additionally being explored in nonclinical research for its potential to reduce liver fibrosis and lessen hepatocellular carcinoma tumor loads in experimental models of NASH. Moreover, Rencofilstat has exh...[Read more]
Industry
Biotechnology
IPO Date
2014-02-10
Stock Exchange
OTC
Ticker
HEPA
According to Hepion Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 0.04. This represents a change of -116.97% compared to the average of -0.24 of the last 4 quarters.
The mean historical PE Ratio of Hepion Pharmaceuticals, Inc. over the last ten years is -12.19. The current 0.04 PE Ratio has changed -132.82% with respect to the historical average. Over the past ten years (40 quarters), HEPA's PE Ratio was at its highest in in the June 2017 quarter at 0. The PE Ratio was at its lowest in in the December 2016 quarter at -199.94.
Average
-12.19
Median
-0.79
Minimum
-113.51
Maximum
-0.07
Discovering the peaks and valleys of Hepion Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 6.76%
Maximum Annual PE Ratio = -0.07
Minimum Annual Increase = -98.37%
Minimum Annual PE Ratio = -113.51
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -0.07 | -68.86% |
| 2024 | -0.22 | -16.71% |
| 2023 | -0.26 | -51.52% |
| 2022 | -0.54 | -77.85% |
| 2021 | -2.45 | 135.19% |
| 2020 | -1.04 | -33.09% |
| 2019 | -1.56 | 305.08% |
| 2018 | -0.38 | -79.30% |
| 2017 | -1.86 | -98.37% |
| 2017 | -113.51 | 6.76% |
The current PE Ratio of Hepion Pharmaceuticals, Inc. (HEPA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-0.18
5-year avg
-0.71
10-year avg
-12.19
Hepion Pharmaceuticals, Inc.’s PE Ratio is greater than CDT Equity Inc. (0.00), greater than ZyVersa Therapeutics, Inc. (-0.87), greater than SCWorx Corp. (-0.28), greater than Longevity Health Holdings Inc. (-0.07), greater than NewGenIvf Group Limited (0.04), greater than Envoy Medical, Inc. (-1.87), greater than Lixte Biotechnology Holdings, Inc. (-9.27), greater than Enveric Biosciences, Inc. (-0.28), greater than Surrozen, Inc. (-0.75), less than Petros Pharmaceuticals, Inc. (0.10),
| Company | PE Ratio | Market cap |
|---|---|---|
| 0.00 | $3.38M | |
| -0.87 | $1.58M | |
| -0.28 | $303.46K | |
| -0.07 | $373.13K | |
| 0.04 | $318.84K | |
| -1.87 | $13.06M | |
| -9.27 | $71.84M | |
| -0.28 | $913.43K | |
| -0.75 | $174.90M | |
| 0.10 | $218.12K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hepion Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Hepion Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Hepion Pharmaceuticals, Inc.'s PE Ratio?
How is the PE Ratio calculated for Hepion Pharmaceuticals, Inc. (HEPA)?
What is the highest PE Ratio for Hepion Pharmaceuticals, Inc. (HEPA)?
What is the 3-year average PE Ratio for Hepion Pharmaceuticals, Inc. (HEPA)?
What is the 5-year average PE Ratio for Hepion Pharmaceuticals, Inc. (HEPA)?
How does the current PE Ratio for Hepion Pharmaceuticals, Inc. (HEPA) compare to its historical average?